Cobb Stuart

Track

Insider profile

Cobb Stuart's trades of Neurogene Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
280.62
Quantity 22,101 -22.9%
Value US$2,616,782
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
183.75
Quantity 97,726 -26.6%
Value US$1,496,731
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
107.30
Quantity 69,307 -48.0%
Value US$3,805,203
US Neurogene Inc (NGNE)
Transaction date
Proposed sale
Price
22.30
Quantity 6,797
Value US$151,573
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
15.15
Quantity 6,797 -24.6%
Value US$103,003
US Neurogene Inc (NGNE)
Transaction date
Proposed sale
Price
15.51
Quantity 6,797
Value US$105,421
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-17 2026-03-13
US Neurogene Inc (NGNE)
PlS Planned sale
22,101 -22.9%
280.62
US$2,616,782 		22,101 -22.9% 280.62 US$2,616,782
2026-03-17 2026-03-13
US Neurogene Inc (NGNE)
PlS Planned sale
97,726 -26.6%
183.75
US$1,496,731 		97,726 -26.6% 183.75 US$1,496,731
2026-03-17 2026-03-13
US Neurogene Inc (NGNE)
PlS Planned sale
69,307 -48.0%
107.30
US$3,805,203 		69,307 -48.0% 107.30 US$3,805,203
2026-03-13 2026-03-13
US Neurogene Inc (NGNE)
PrS Proposed sale
6,797
22.30
US$151,573 		6,797 22.30 US$151,573
2025-05-15 2025-05-14
US Neurogene Inc (NGNE)
PlS Planned sale
6,797 -24.6%
15.15
US$103,003 		6,797 -24.6% 15.15 US$103,003
2025-05-14 2025-05-14
US Neurogene Inc (NGNE)
PrS Proposed sale
6,797
15.51
US$105,421 		6,797 15.51 US$105,421